![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
WE Mol, GN Fokkema, B Weert and DK Meijer
Department of Pharmacology and Therapeutics, University of Groningen, The Netherlands.
In hepatobiliary transport of organic cations some remarkable differences have been reported between the monovalent compounds (prototype procainamidethobromide) and the potentially bivalent cations, containing a second quaternary ammonium group or a protonated tertiary amine function (prototype d-tubocurarine). In order to characterize the hepatic uptake mechanism for such bivalent cations in more detail, we studied the uptake of the steroidal muscle relaxant vecuronium in isolated rat hepatocytes. Uptake occurred by both a saturable (Vmax = 181 pmol/min x 10(6) cells, Km = 15 microM) and a nonsaturable process (rate constant = 1.10 pmol/min/10(6) cells/microM). The uptake of vecuronium was reduced by various metabolic inhibitors and by sulfhydryl-blocking agents. The transport system showed temperature dependency with an activation energy of 85 kJ/mol. Sodium replacement by lithium or choline in the extracellular medium had no effect on the uptake of vecuronium. Replacement of sodium chloride by sucrose led to a decrease of the uptake, whereas chloride replacement by bicarbonate or iodide stimulated the vecuronium uptake. These data point to a significant anion-dependency of the uptake system and indicate electroneutral uptake of vecuronium. The uptake of vecuronium was inhibited by a variety of hepatic transport model compounds, including bile acids, uncharged compounds and high molecular weight organic cations. Low molecular weight monovalent cations had no effect on the uptake of vecuronium.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  J. E. van Montfoort, M. Muller, G. M. M. Groothuis, D. K. F. Meijer, H. Koepsell, and P. J. Meier Comparison of ""Type I"" and ""Type II"" Organic Cation Transport by Organic Cation Transporters and Organic Anion-Transporting Polypeptides J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 110 - 115. [Abstract] [Full Text]
|
|
|
|
|
|
L. Zhang, W. Gorset, M. J. Dresser, and K. M. Giacomini The Interaction of n-Tetraalkylammonium Compounds with a Human Organic Cation Transporter, hOCT1 J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1192 - 1198. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Nagel, C. Volk, T. Friedrich, J. C. Ulzheimer, E. Bamberg, and H. Koepsell A Reevaluation of Substrate Specificity of the Rat Cation Transporter rOCT1 J. Biol. Chem., December 19, 1997; 272(51): 31953 - 31956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Proost, J. Roggeveld, J. M. K. H. Wierda, and D. K. F. Meijer Relationship between Chemical Structure and Physicochemical Properties of Series of Bulky Organic Cations and Their Hepatic Uptake and Biliary Excretion Rates J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 715 - 726. [Abstract] [Full Text]
|
|
|
|
|
|
H. Sasabe, T. Terasaki, A. Tsuji, and Y. Sugiyama Carrier-Mediated Hepatic Uptake of Quinolone Antibiotics in the Rat J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 162 - 171. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Zhang, M. J. Dresser, A. T. Gray, S. C. Yost, S. Terashita, and K. M. Giacomini Cloning and Functional Expression of a Human Liver Organic Cation Transporter Mol. Pharmacol., June 1, 1997; 51(6): 913 - 921. [Abstract] [Full Text]
|
|
|
|
|
|
R. H. Moseley, L. J. Zugger, and R. W. Van Dyke The Neurotoxin 1-Methyl-4-phenylpyridinium Is a Substrate for the Canalicular Organic Cation/H+ Exchanger J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 34 - 40. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
